Kodiak Sciences Inc.

NasdaqGM:KOD 주식 보고서

시가총액: US$325.0m

Kodiak Sciences 관리

관리 기준 확인 4/4

Kodiak Sciences CEO는 Victor Perlroth, Jun2009 에 임명되었습니다 의 임기는 15.42 년입니다. 총 연간 보상은 $ 2.73M, 26.4% 로 구성됩니다. 26.4% 급여 및 73.6% 보너스(회사 주식 및 옵션 포함). 는 $ 16.31M 가치에 해당하는 회사 주식의 5.02% 직접 소유합니다. 16.31M. 경영진과 이사회의 평균 재임 기간은 각각 3.3 년과 6.4 년입니다.

주요 정보

Victor Perlroth

최고 경영자

US$2.7m

총 보상

CEO 급여 비율26.4%
CEO 임기15.4yrs
CEO 소유권5.0%
경영진 평균 재임 기간3.3yrs
이사회 평균 재임 기간6.4yrs

최근 관리 업데이트

Recent updates

Kodiak: Tarcocimab Faces High Barriers To Entry Despite Resurrection (Rating Upgrade)

Nov 15

We Think Kodiak Sciences (NASDAQ:KOD) Needs To Drive Business Growth Carefully

Aug 02
We Think Kodiak Sciences (NASDAQ:KOD) Needs To Drive Business Growth Carefully

We Think Kodiak Sciences (NASDAQ:KOD) Needs To Drive Business Growth Carefully

Apr 17
We Think Kodiak Sciences (NASDAQ:KOD) Needs To Drive Business Growth Carefully

We Think Kodiak Sciences (NASDAQ:KOD) Needs To Drive Business Growth Carefully

Dec 29
We Think Kodiak Sciences (NASDAQ:KOD) Needs To Drive Business Growth Carefully

We're Keeping An Eye On Kodiak Sciences' (NASDAQ:KOD) Cash Burn Rate

Sep 09
We're Keeping An Eye On Kodiak Sciences' (NASDAQ:KOD) Cash Burn Rate

Is Kodiak Sciences (NASDAQ:KOD) In A Good Position To Deliver On Growth Plans?

May 26
Is Kodiak Sciences (NASDAQ:KOD) In A Good Position To Deliver On Growth Plans?

We Think Kodiak Sciences (NASDAQ:KOD) Needs To Drive Business Growth Carefully

Jan 04
We Think Kodiak Sciences (NASDAQ:KOD) Needs To Drive Business Growth Carefully

Here's Why We're Watching Kodiak Sciences' (NASDAQ:KOD) Cash Burn Situation

Sep 25
Here's Why We're Watching Kodiak Sciences' (NASDAQ:KOD) Cash Burn Situation

GreenWood Investors - Kodiak Sciences: The Busted Biotech World

Aug 25

Kodiak Sciences FQ1 2022 Earnings Preview

Aug 07

Is Kodiak Sciences (NASDAQ:KOD) In A Good Position To Invest In Growth?

May 18
Is Kodiak Sciences (NASDAQ:KOD) In A Good Position To Invest In Growth?

Kodiak Sciences: Potential For Comeback After Trial Setback

May 17

Kodiak Sciences: KSI-301 Disappoints

Feb 25

Highlighting Kodiak Sciences: A Great Buy Here Ahead Of Phase 3 Wet AMD Data For KSI-301 This Quarter

Feb 15

We're Hopeful That Kodiak Sciences (NASDAQ:KOD) Will Use Its Cash Wisely

Jan 24
We're Hopeful That Kodiak Sciences (NASDAQ:KOD) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Kodiak Sciences' (NASDAQ:KOD) Cash Burn Situation

Oct 11
Here's Why We're Not Too Worried About Kodiak Sciences' (NASDAQ:KOD) Cash Burn Situation

Kodiak Sciences: Our Current Take On This Mid-Cap Biotech Company

Jul 19

Kodiak Sciences EPS in-line

May 10

Kodiak Sciences hits the capital raise button; shares dip after hours

Nov 16

Kodiak Sciences EPS misses by $0.12

Nov 09

CEO 보상 분석

Victor Perlroth 의 보수는 Kodiak Sciences 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

-US$192m

Jun 30 2024n/an/a

-US$198m

Mar 31 2024n/an/a

-US$233m

Dec 31 2023US$3mUS$721k

-US$260m

Sep 30 2023n/an/a

-US$271m

Jun 30 2023n/an/a

-US$298m

Mar 31 2023n/an/a

-US$309m

Dec 31 2022US$3mUS$691k

-US$334m

Sep 30 2022n/an/a

-US$357m

Jun 30 2022n/an/a

-US$347m

Mar 31 2022n/an/a

-US$312m

Dec 31 2021US$113mUS$655k

-US$267m

Sep 30 2021n/an/a

-US$220m

Jun 30 2021n/an/a

-US$189m

Mar 31 2021n/an/a

-US$159m

Dec 31 2020US$9mUS$591k

-US$133m

Sep 30 2020n/an/a

-US$102m

Jun 30 2020n/an/a

-US$78m

Mar 31 2020n/an/a

-US$64m

Dec 31 2019US$18mUS$526k

-US$47m

Sep 30 2019n/an/a

-US$46m

Jun 30 2019n/an/a

-US$44m

Mar 31 2019n/an/a

-US$41m

Dec 31 2018US$6mUS$428k

-US$41m

Sep 30 2018n/an/a

-US$38m

Jun 30 2018n/an/a

-US$32m

Mar 31 2018n/an/a

-US$31m

Dec 31 2017US$824kUS$388k

-US$28m

보상 대 시장: Victor 의 총 보상 ($USD 2.73M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 2.14M ).

보상과 수익: Victor 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Victor Perlroth (51 yo)

15.4yrs

테뉴어

US$2,725,068

보상

Dr. Victor Perlroth, M.D co-founded Kodiak Sciences Inc. in 2009 and serves as its co-founder, Chairman, President and Chief Executive Officer. Dr. Perlroth serves as Chief Executive officer since June 200...

리더십 팀

이름위치테뉴어보상소유권
Victor Perlroth
Co-Founder15.4yrsUS$2.73m5.02%
$ 16.3m
John Borgeson
Executive VP10.4yrsUS$1.68m0.35%
$ 1.1m
Dolly Chang
Chief Scientific Officerless than a year데이터 없음데이터 없음
Hong Liang
Senior Vice President of Development7.1yrsUS$321.91k데이터 없음
Stephen Raillard
Senior Vice President of Chemical Development & Manufacturing1.8yrs데이터 없음데이터 없음
Almas Qudrat
Chief Quality Officer4.8yrs데이터 없음데이터 없음
J. Velazquez-Martin
Chief Medical Officer1.8yrs데이터 없음데이터 없음
Tracy Chien
VP & Corporate Controller1.8yrs데이터 없음데이터 없음

3.3yrs

평균 재임 기간

52yo

평균 연령

경험이 풍부한 관리: KOD 의 관리팀은 경험 ( 3.3 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Victor Perlroth
Co-Founder15.4yrsUS$2.73m5.02%
$ 16.3m
Robert Profusek
Lead Independent Director6.4yrsUS$248.40k0.019%
$ 61.9k
Felix Baker
Independent Director9.2yrsUS$161.90k0%
$ 0
Richard Levy
Independent Director6.4yrsUS$211.90k0.0019%
$ 6.2k
Bassil Dahiyat
Independent Director6.4yrsUS$216.90k0%
$ 0
Charles Bancroft
Independent Director4.6yrsUS$239.40k0.049%
$ 160.6k
David Boyer
Scientific Advisorno data데이터 없음데이터 없음
Michael IP
Scientific Advisorno data데이터 없음데이터 없음
Sunil Patel
Scientific Advisorno data데이터 없음데이터 없음
David Brown
Scientific Advisorno data데이터 없음데이터 없음
Carl Regillo
Scientific Advisorno data데이터 없음데이터 없음
Pravin Dugel
Scientific Advisorno data데이터 없음데이터 없음

6.4yrs

평균 재임 기간

60yo

평균 연령

경험이 풍부한 이사회: KOD 의 이사회는 경험(평균 재직 기간 6.4 년)으로 간주됩니다.